Experts Debate Whether IRA Provisions Stifle Pharma Innovation at Senate Hearing
Rena Conti, quoted in MedPage Today, September 18, 2024.
Tag: Rena Conti
An obscure drug discount program stifles use of federal lifeline by rural hospitals
Rena Conti, TPRI Faculty Director quoted in Stateline, May 28, 2024.
Sizing A Market Entry Reward for the Development of New Antibiotics
Eric J. Evans, Alexandre Meyer, Rena M. Conti’s paper “Sizing A Market Entry Reward for the Development of New Antibiotics” M-RCBG Associate Working Paper No. 232, Mossavar-Rahmani Center for Business & Government, Harvard Kennedy School, May 2024.
Biopharma Venture Capital And The Inflation Reduction Act
Matthew Vogel, Rena M. Conti, and Amitabh Chandra’s article “Biopharma Venture Capital And The Inflation Reduction Act”
Health Affairs Forefront, March 5, 2024.
The Inflation Reduction Act Coinsurance Glitch
Mark V. Pauly, Debra M. Lederman, and Rena M. Conti’s article “The Inflation Reduction Act Coinsurance Glitch”
Health Affairs Forefront, January 17, 2024.
How rock-bottom prices drive shortages of generic drugs used in hospitals
Rena Conti, TPRI Faculty Director, quoted in NPR, December 28, 2023.
Critical Technology Assessment for biopharmaceuticals: Insights from a one-year pilot
Marta Wosińska and Rena Conti, TPRI Faculty Director, article
“Critical Technology Assessment for biopharmaceuticals: Insights from a one-year pilot” Brookings Institution, November 1, 2023.
The estimated annual financial impact of gene therapy in the United States
By Chi Heem Wong, Dexin Li, Nina Wang, Jonathan Gruber, Andrew W. Lo & Rena M. Conti
Gene therapy is a new class of medical treatment that alters part of a patient’s genome through the replacement, deletion, or insertion of genetic material.
People are underestimating the significance of drug pricing provisions in Inflation Reduction Act
Rena Conti, Leslie Dach and Richard Frank, Opinion Article The Hill, October 6, 2023.
Bipartisan battle over prescription intermediaries heats up
Rena Conti, TPRI Faculty Director, quoted in The Hill, 09/28/23